2,3-Dihydroxypropyl 2-(((7-chloroquinolin-4-yl)amino)benzoate

Catalog No. :
ACAUSL942
CAS No. :
3820-67-5
Molecular Formula :
C19H17ClN2O4
Molecular Weight :
372.81

IUPAC Name:2,3-dihydroxypropyl 2-((7-chloroquinolin-4-yl)amino)benzoate

2,3-Dihydroxypropyl 2-(((7-chloroquinolin-4-yl)amino)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$56.00Login to see priceIn stockInquiry
5g98%$171.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dihydroxypropyl 2-(((7-chloroquinolin-4-yl)amino)benzoate
IUPAC Name2,3-dihydroxypropyl 2-((7-chloroquinolin-4-yl)amino)benzoate
MDL No.MFCD00079326
Molecular FormulaC19H17ClN2O4
Molecular Weight372.81
SMILESO=C(OCC(O)CO)C1=CC=CC=C1NC2=CC=NC3=CC(Cl)=CC=C23
InChI KeyGWOFUCIGLDBNKM-UHFFFAOYSA-N
SynonymSpectrum4_000830 | CS-4757 | KBio2_006828 | AKOS016012374 | BRD-A38076815-003-03-8 | Glaphenine | IDI1_000295 | SR-01000473478-4 | 2,3-Dihydroxypropyl N-(7-chloro-4-quinolyl) anthranilate | BDBM50103508 | AB00052189_09 | Benzoic acid, 2-((7-chloro-4-quino
CAS No.3820-67-5
PubChem CID3474

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAUSL942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUSL942 route product structure diagram
    ACAUSL9423820-67-5 In Stock
Inquiry

2. ACAUSL942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUSL942 route product structure diagram
    ACAUSL9423820-67-5 In Stock
Inquiry

Comments (0)